Header Logo

Connection

Maria Paximadis to Receptors, CCR5

This is a "connection" page, showing publications Maria Paximadis has written about Receptors, CCR5.
Connection Strength

0,808
  1. Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers. Front Immunol. 2021; 12:781263.
    View in: PubMed
    Score: 0,190
  2. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clin Immunol. 2019 08; 205:16-24.
    View in: PubMed
    Score: 0,159
  3. CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships. Immunology. 2017 08; 151(4):464-473.
    View in: PubMed
    Score: 0,138
  4. CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations. Immunogenetics. 2012 Nov; 64(11):795-806.
    View in: PubMed
    Score: 0,099
  5. Marked differences in CCR5 expression and activation levels in two South African populations. Immunology. 2012 Aug; 136(4):397-407.
    View in: PubMed
    Score: 0,099
  6. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations. Infect Genet Evol. 2010 May; 10(4):487-94.
    View in: PubMed
    Score: 0,084
  7. A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation. Nat Commun. 2019 01 24; 10(1):412.
    View in: PubMed
    Score: 0,039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.